Showing results (471-480 of 632) with videos related to

Sort By:
Pageof 64
Antiviral Therapy|February 22, 2007
A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trialZoe Fox, Ulrik B Dragsted, Jan Gerstoft, et al.
Vaccine|April 1, 1997
European contribution to the science, prevention and management of HIV infectionT Lehner, P Biberfeld, C Boucher, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 4, 2013
The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infectionC da Cunha-Bang, N Kirkby, M Sønderholm, et al.
HIV Medicine|November 10, 2015
Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive personsL Ryom, C Boesecke, V Gisler, et al.
Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 1, 1996
Tuberculosis among European patients with the acquired immune deficiency syndrome. The AIDS in Europe Study GroupP Sudre, B J Hirschel, J M Gatell, et al.
Scandinavian Journal of Infectious Diseases|February 11, 2011
Factors associated with the development of cytomegalovirus infection following solid organ transplantationCaspar da Cunha-Bang, Søren S Sørensen, Martin Iversen, et al.
International Journal of Epidemiology|July 27, 2007
A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected menMargaret May, Jonathan A C Sterne, Martin Shipley, et al.
AIDS (London, England)|March 28, 2003
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral loadJuan A Arnaiz, Josep Mallolas, Daniel Podzamczer, et al.
Plos Medicine|April 1, 2015
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D studyAmanda Mocroft, Jens D Lundgren, Michael Ross, et al.
Diabetes Care|December 6, 2008
Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) studySigne W Worm, Caroline A Sabin, Peter Reiss, et al.
Pageof 64